Werbung
Werbung

TELA

TELA logo

TELA Bio, Inc. Common Stock

1.09
USD
Gesponsert
0.00
0.00%
09. Jan., 15:44 UTC -5
Geschlossen
exchange

Nach-Markt

1.09

0.00
0.00%

TELA Ergebnisberichte

Positives Überraschungsverhältnis

TELA übertreffen die 7 der letzten 25Schätzungen.

28%

Nächster Bericht

Datum des nächsten Berichts
18. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$21.47M
/
-$0.18
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+3.77%
/
-5.26%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
+21.64%
/
-21.74%

TELA Bio, Inc. Common Stock earnings per share and revenue

On 13. Nov. 2025, TELA reported earnings of -0.19 USD per share (EPS) for Q3 25, beating the estimate of -0.20 USD, resulting in a 6.40% surprise. Revenue reached 20.69 million, compared to an expected 22.22 million, with a -6.91% difference. The market reacted with a -9.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 7 analysts forecast an EPS of -0.18 USD, with revenue projected to reach 21.47 million USD, implying an decrease of -5.26% EPS, and increase of 3.77% in Revenue from the last quarter.
FAQ
For Q3 2025, TELA Bio, Inc. Common Stock reported EPS of -$0.19, beating estimates by 6.4%, and revenue of $20.69M, -6.91% below expectations.
The stock price moved down -9.97%, changed from $1.11 before the earnings release to $1.00 the day after.
The next earning report is scheduled for 18. März 2026.
Based on 7 analysts, TELA Bio, Inc. Common Stock is expected to report EPS of -$0.18 and revenue of $21.47M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung